Henry Ford Health System, Division of Gastroenterology & Hepatology

2799 West Grand Boulevard
Detroit, Michigan 48202

We've found

1 trials

at this facility

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Detroit, MI

Use our guide to learn which trials are right for you!